For this purpose, we correlated alterations of TP53 and BNIP3 in tumour cells with expression of hypoxia-related proteins HIF-2α and CA9 in relation with patient outcome and apoptotic activity in CRCs. This evidence concerns the gene EPAS1 and neoplasm.